Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Holdings Inc has demonstrated a significant improvement in its financial performance, highlighted by an increase in EBITDA margin both sequentially and year-over-year, with gross margins reaching 70.1%, exceeding industry consensus. The company's successful launch of the Motiva product line has invigorated the breast aesthetics market, leading to a reported 15% year-over-year increase in procedure volumes for practices that adopted Motiva. Furthermore, Establishment Labs expects to finish 2026 with a notable increase in cash reserves, forecasting $75.5 million, up from $71 million in the previous year, indicating strong financial positioning and growth potential.

Bears say

Establishment Labs Holdings Inc. is facing a negative outlook due to anticipated revenue growth falling below 20%, attributed to weaker-than-expected sales in the U.S. market and a slower trajectory toward profitability. Additionally, international growth has shown significant deceleration, with projections indicating minimal growth—approximately 2%—for both 2024 and 2025. The company is also confronted with several risks, including disappointing U.S. sales, potential economic downturns affecting international demand, and uncertainties surrounding real-world complication rates related to its products.

ESTA has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 7 analysts, ESTA has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.